Robert S Mastman, MD
Ophthalmology · Cupertino
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 29
- 7 carriers
- Office
- 1
On the public record
- Owns El Camino Ambulatory Surgery Center LLC: Accreditation Revoked
Offices
1 location · Spectrum Eye Physicians A Medical Corporation · 15 clinicians in this group
Looking this up.
Plans that list them
29 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mastman’s office at (408) 253-3083 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A37122 · Current
Licensed to practise in California · since 1981 · expires 2027-03-31 · Autonomous University of Guadalajara Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- El Camino Ambulatory Surgery Center LLCAmbulatory Surgery Center · Mountain View, CA3.25% owner since 2013 · accredited by AAAHCAccreditation Revoked2 inspections · last 2018-04-05
Original Medicare doctor bills
$261,546
Medicare paid this office $261,546 for 1,261 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 722 | $103,045 | $119 |
| Established patient problem focused exam of visual system | 341 | $48,343 | $87 |
| New patient visit (45+ min) | 171 | $25,468 | $149 |
| Exam of visual field with extended testing | 234 | $15,891 | $67 |
| Imaging of retina | 363 | $15,258 | $41 |
See all 14 services
| Return visit (30+ min) | 722 | $103,045 | $119 |
| Established patient problem focused exam of visual system | 341 | $48,343 | $87 |
| New patient visit (45+ min) | 171 | $25,468 | $149 |
| Exam of visual field with extended testing | 234 | $15,891 | $67 |
| Imaging of retina | 363 | $15,258 | $41 |
| Established patient complete exam of visual system | 104 | $13,254 | $124 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $11,682 | $354 |
| Photography of the retina | 287 | $11,330 | $39 |
| Imaging of optic nerve | 162 | $5,946 | $36 |
| New patient complete exam of visual system | 24 | $3,398 | $142 |
| New patient problem focused exam of visual system | 39 | $3,161 | $81 |
| Ultrasound scan of cornea to determine thickness | 42 | $442 | $11 |
| Exam of the internal drainage system of eye | 18 | $440 | $24 |
| Removal of eyelashes using forceps | 12 | $305 | $22 |
Procedures Medicare counted
| Cataract surgery | 32 | More than 54% of doctors who do this |
Who their Medicare patients are
1,261 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 19% · Women 62% · Also on Medicaid 8% · Health risk score 1.11. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 72% · Diabetes 36% · Coronary heart disease 28% · Chronic kidney disease 22% · Atrial fibrillation 18% · Cancer 17% · Depression 15% · Heart failure 14% · COPD 10% · Stroke 7% · Dementia 5%.
The office billed $538,575, Medicare allowed $356,581 and paid $261,546; for 2,962 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,261 | 2,962 | 77 | 1.11 | $538,575 | $261,546 |
| 2023 | 1,325 | 3,048 | 77 | 1.06 | $507,677 | $245,358 |
| 2022 | 1,343 | 3,091 | 77 | 1.04 | $507,045 | $250,223 |
| 2021 | 1,244 | 2,935 | 77 | 1.00 | $504,390 | $249,365 |
| 2020 | 979 | 2,195 | 77 | 1.06 | $374,885 | $170,824 |
| 2019 | 1,240 | 2,701 | 77 | 1.04 | $559,605 | $230,887 |
| 2018 | 1,259 | 3,078 | 77 | 1.08 | $1,003,424 | $324,511 |
| 2017 | 1,238 | 2,938 | 77 | 1.05 | $932,049 | $319,911 |
| 2016 | 1,267 | 3,114 | 77 | 1.09 | $972,275 | $338,798 |
| 2015 | 1,271 | 3,152 | 77 | 1.01 | $938,543 | $345,701 |
| 2014 | 1,318 | 3,235 | 77 | 0.94 | $1,065,313 | $376,077 |
| 2013 | 1,253 | 2,952 | 77 | 0.97 | $893,829 | $324,634 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 672 | $83,051 | $107 |
| Established patient problem focused exam of visual system | 403 | $50,630 | $82 |
| New patient visit (45+ min) | 190 | $26,252 | $138 |
| Exam of visual field with extended testing | 271 | $17,201 | $63 |
| Established patient complete exam of visual system | 129 | $14,507 | $110 |
| Imaging of retina | 340 | $13,034 | $38 |
| Photography of the retina | 298 | $10,539 | $35 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $10,277 | $332 |
| Imaging of optic nerve | 178 | $5,938 | $33 |
| New patient complete exam of visual system | 46 | $5,662 | $123 |
| New patient problem focused exam of visual system | 61 | $4,564 | $75 |
| Ultrasound scan of cornea to determine thickness | 45 | $478 | $11 |
| Exam of the internal drainage system of eye | 16 | $392 | $25 |
2022: 13 services
| Return visit (30+ min) | 675 | $82,273 | $109 |
| Established patient problem focused exam of visual system | 373 | $49,216 | $82 |
| Established patient complete exam of visual system | 238 | $24,747 | $98 |
| New patient visit (45+ min) | 143 | $20,348 | $142 |
| Exam of visual field with extended testing | 250 | $15,165 | $60 |
| Imaging of retina | 339 | $13,035 | $37 |
| Removal of recurring cataract in lens capsule using a laser | 32 | $11,633 | $323 |
| Photography of the retina | 313 | $11,078 | $35 |
| New patient complete exam of visual system | 88 | $10,545 | $120 |
| Imaging of optic nerve | 173 | $5,888 | $33 |
| New patient problem focused exam of visual system | 37 | $2,519 | $68 |
| Exam of the internal drainage system of eye | 12 | $360 | $26 |
| Ultrasound scan of cornea to determine thickness | 27 | $279 | $10 |
2021: 15 services
| Established patient complete exam of visual system | 627 | $78,714 | $113 |
| Established patient problem focused exam of visual system | 363 | $44,751 | $82 |
| Return visit (30+ min) | 219 | $24,584 | $103 |
| New patient complete exam of visual system | 140 | $18,170 | $130 |
| Removal of recurring cataract in lens capsule using a laser | 42 | $15,426 | $335 |
| Exam of visual field with extended testing | 237 | $14,984 | $62 |
| New patient visit (45+ min) | 94 | $13,457 | $143 |
| Imaging of retina | 297 | $11,780 | $39 |
| Photography of the retina | 285 | $11,144 | $37 |
| Imaging of optic nerve | 162 | $5,490 | $33 |
| New patient visit (30+ min) | 22 | $2,134 | $97 |
| Short return visit (20+ min) | 17 | $1,536 | $77 |
| New patient problem focused exam of visual system | 18 | $1,439 | $80 |
| Ultrasound scan of cornea to determine thickness | 51 | $544 | $11 |
| Exam of the internal drainage system of eye | 12 | $398 | $28 |
2020: 16 services
| Established patient complete exam of visual system | 358 | $39,591 | $103 |
| Established patient problem focused exam of visual system | 329 | $38,108 | $79 |
| Return visit (30+ min) | 232 | $20,667 | $88 |
| Exam of visual field with extended testing | 186 | $11,813 | $62 |
| Removal of recurring cataract in lens capsule using a laser | 34 | $11,702 | $316 |
| New patient complete exam of visual system | 98 | $11,221 | $114 |
| Photography of the retina | 196 | $8,901 | $44 |
| New patient visit (45+ min) | 68 | $8,704 | $128 |
| Imaging of retina | 219 | $8,362 | $37 |
| Imaging of optic nerve | 121 | $4,093 | $33 |
| New patient visit (30+ min) | 18 | $1,623 | $90 |
| Short return visit (20+ min) | 24 | $1,349 | $54 |
| New patient problem focused exam of visual system | 14 | $1,037 | $74 |
| Removal of eyelashes using forceps | 13 | $388 | $26 |
| Ultrasound scan of cornea to determine thickness | 32 | $364 | $11 |
| Imaging of front third of eye | 12 | $352 | $25 |
2019: 17 services
| Return visit (30+ min) | 747 | $71,317 | $85 |
| Established patient problem focused exam of visual system | 259 | $24,154 | $77 |
| Established patient complete exam of visual system | 178 | $20,794 | $116 |
| Removal of cataract with insertion of prosthetic lens | 24 | $18,729 | $624 |
| Removal of recurring cataract in lens capsule using a laser | 42 | $14,949 | $332 |
| Exam of visual field with extended testing | 203 | $13,230 | $63 |
| New patient visit (45+ min) | 88 | $11,652 | $132 |
| Short return visit (20+ min) | 155 | $10,776 | $63 |
| Imaging of retina | 235 | $8,821 | $37 |
| Photography of the retina | 175 | $8,761 | $48 |
| New patient complete exam of visual system | 60 | $7,498 | $125 |
| Imaging of optic nerve | 143 | $4,642 | $32 |
| New patient visit (30+ min) | 30 | $2,893 | $96 |
| Measurement of corneal curvature and depth of eye | 29 | $1,881 | $26 |
| New patient problem focused exam of visual system | 18 | $1,288 | $72 |
| Imaging of front third of eye | 12 | $333 | $28 |
| Ultrasound scan of cornea to determine thickness | 23 | $269 | $12 |
2018: 17 services
| Removal of cataract with insertion of prosthetic lens | 110 | $91,798 | $581 |
| Established patient complete exam of visual system | 538 | $52,420 | $95 |
| Return visit (30+ min) | 432 | $43,834 | $96 |
| Established patient problem focused exam of visual system | 341 | $32,910 | $70 |
| Removal of recurring cataract in lens capsule using a laser | 51 | $17,829 | $313 |
| New patient complete exam of visual system | 122 | $13,332 | $109 |
| Exam of visual field with extended testing | 187 | $11,754 | $62 |
| Short return visit (20+ min) | 147 | $10,565 | $66 |
| Measurement of corneal curvature and depth of eye | 107 | $9,736 | $36 |
| Photography of the retina | 171 | $9,576 | $56 |
| Imaging of retina | 167 | $6,585 | $38 |
| New patient visit (45+ min) | 42 | $6,010 | $143 |
| Imaging of optic nerve | 123 | $3,974 | $32 |
| New patient problem focused exam of visual system | 29 | $2,194 | $76 |
| Removal of eyelashes using forceps | 11 | $491 | $41 |
| Ct scan of cornea | 11 | $384 | $35 |
| Ultrasound scan of cornea to determine thickness | 19 | $243 | $13 |
2017: 18 services
| Removal of cataract with insertion of prosthetic lens | 94 | $78,419 | $599 |
| Established patient complete exam of visual system | 731 | $78,103 | $101 |
| Established patient problem focused exam of visual system | 517 | $56,671 | $73 |
| Removal of recurring cataract in lens capsule using a laser | 54 | $20,791 | $310 |
| New patient complete exam of visual system | 156 | $19,144 | $123 |
| Exam of visual field with extended testing | 196 | $12,176 | $61 |
| Photography of the retina | 184 | $11,949 | $64 |
| Measurement of corneal curvature and depth of eye | 72 | $6,958 | $70 |
| Imaging of retina | 180 | $6,861 | $37 |
| Return visit (30+ min) | 58 | $5,216 | $88 |
| Laser repair to improve eye fluid flow | 11 | $3,757 | $235 |
| Imaging of optic nerve | 111 | $3,614 | $32 |
| New patient problem focused exam of visual system | 35 | $2,332 | $67 |
| Ultrasound scan to determine eye length and lens power | 25 | $1,918 | $77 |
| Removal of eyelashes using forceps | 11 | $500 | $45 |
| Ultrasound scan of cornea to determine thickness | 24 | $317 | $13 |
| Exam of the internal drainage system of eye | 13 | $259 | $20 |
| Imaging of front third of eye | 11 | $252 | $23 |
2016: 16 services
| Removal of cataract with insertion of prosthetic lens | 109 | $89,414 | $592 |
| Established patient complete exam of visual system | 773 | $82,710 | $101 |
| Established patient problem focused exam of visual system | 561 | $64,412 | $74 |
| New patient complete exam of visual system | 143 | $17,819 | $125 |
| Removal of recurring cataract in lens capsule using a laser | 44 | $15,055 | $314 |
| Photography of the retina | 184 | $14,376 | $76 |
| Exam of visual field with extended testing | 211 | $13,149 | $61 |
| Ultrasound scan to determine eye length and lens power | 99 | $7,965 | $72 |
| Imaging of retina | 174 | $7,341 | $41 |
| Return visit (30+ min) | 64 | $6,250 | $96 |
| Imaging of optic nerve | 136 | $5,410 | $39 |
| New patient problem focused exam of visual system | 36 | $2,339 | $65 |
| Removal of eyelashes using forceps | 18 | $1,154 | $46 |
| Exam of the internal drainage system of eye | 16 | $361 | $23 |
| Imaging of front third of eye | 11 | $337 | $31 |
| Ultrasound scan of cornea to determine thickness | 19 | $258 | $14 |
2015: 19 services
| Established patient complete exam of visual system | 834 | $96,566 | $106 |
| Removal of cataract with insertion of prosthetic lens | 94 | $76,750 | $604 |
| Established patient problem focused exam of visual system | 550 | $65,372 | $75 |
| Exam of visual field with extended testing | 241 | $15,539 | $63 |
| Photography of the retina | 183 | $15,145 | $80 |
| Removal of recurring cataract in lens capsule using a laser | 38 | $12,444 | $319 |
| New patient complete exam of visual system | 81 | $10,190 | $126 |
| Complex removal of cataract with insertion of prosthetic lens | 12 | $8,997 | $750 |
| Ultrasound scan to determine eye length and lens power | 97 | $8,319 | $79 |
| Imaging of retina | 165 | $7,416 | $43 |
| Imaging of optic nerve | 142 | $5,677 | $40 |
| Return visit (30+ min) | 44 | $3,990 | $91 |
| New patient problem focused exam of visual system | 23 | $1,582 | $69 |
| Short return visit (20+ min) | 17 | $1,234 | $65 |
| Removal of eyelashes using forceps | 14 | $959 | $50 |
| Short return visit | 12 | $547 | $42 |
| Ultrasound scan of cornea to determine thickness | 37 | $506 | $14 |
| Exam of the internal drainage system of eye | 11 | $280 | $23 |
| Photography of content of eyes | 12 | $209 | $17 |
2014: 20 services
| Removal of cataract with insertion of prosthetic lens | 116 | $100,201 | $615 |
| Established patient complete exam of visual system | 713 | $79,764 | $108 |
| Established patient problem focused exam of visual system | 668 | $78,401 | $75 |
| Exam of visual field with extended testing | 237 | $15,558 | $62 |
| Removal of recurring cataract in lens capsule using a laser | 45 | $15,499 | $323 |
| Photography of the retina | 149 | $12,115 | $79 |
| New patient complete exam of visual system | 95 | $11,912 | $125 |
| Ultrasound scan to determine eye length and lens power | 127 | $11,036 | $78 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $9,128 | $761 |
| Imaging of retina | 139 | $6,293 | $44 |
| Imaging of optic nerve | 126 | $5,125 | $40 |
| Return visit (30+ min) | 41 | $3,938 | $94 |
| Removal of growth of eyelid | 11 | $3,284 | $299 |
| New patient problem focused exam of visual system | 45 | $2,814 | $63 |
| Short return visit (20+ min) | 41 | $2,592 | $62 |
| Short return visit | 12 | $475 | $37 |
| Imaging of front third of eye | 15 | $460 | $31 |
| Exam of the internal drainage system of eye | 14 | $390 | $24 |
| Ultrasound scan of cornea to determine thickness | 17 | $234 | $14 |
| Photography of content of eyes | 11 | $198 | $18 |
2013: 19 services
| Removal of cataract with insertion of prosthetic lens | 102 | $82,347 | $615 |
| Established patient problem focused exam of visual system | 539 | $65,504 | $76 |
| Established patient complete exam of visual system | 553 | $57,716 | $102 |
| Return visit (30+ min) | 232 | $24,507 | $93 |
| Exam of visual field with extended testing | 229 | $14,808 | $63 |
| Ultrasound scan to determine eye length and lens power | 105 | $9,372 | $81 |
| New patient complete exam of visual system | 67 | $9,049 | $135 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $8,665 | $321 |
| Photography of the retina | 110 | $7,907 | $71 |
| Short return visit (20+ min) | 90 | $6,281 | $65 |
| Imaging of retina | 129 | $5,545 | $42 |
| Imaging of optic nerve | 129 | $5,244 | $40 |
| New patient visit (30+ min) | 37 | $2,929 | $79 |
| Dilation of tear drainage opening | 12 | $1,785 | $119 |
| New patient visit (45+ min) | 11 | $1,386 | $126 |
| New patient problem focused exam of visual system | 15 | $986 | $66 |
| Exam of the internal drainage system of eye | 20 | $477 | $24 |
| Photography of content of eyes | 18 | $305 | $17 |
| Ultrasound scan of cornea to determine thickness | 14 | $180 | $13 |
Medicaid work
$0 in 2018
Medicaid paid $0 for 15 billed services this clinician did in 2018, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Radiologic examination, chest; single view | 15 | $0 |
| 2018 | 15 | 1 | 12 | $0 |
Drugs they prescribed that Part D paid
$203,552
Pharmacies billed $203,552 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,097) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
415 generic and 682 brand-name prescriptions · $203,552 in drug cost · 34 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 34 | $49,720 | $1,462 |
| Xiidra | 12 | $20,219 | $1,685 |
| Tyrvaya | 26 | $19,809 | $762 |
| Lumigan | 23 | $16,211 | $705 |
| Miebo | 18 | $14,760 | $820 |
See all 21 drugs
| Restasis | 34 | $49,720 | $1,462 |
| Xiidra | 12 | $20,219 | $1,685 |
| Tyrvaya | 26 | $19,809 | $762 |
| Lumigan | 23 | $16,211 | $705 |
| Miebo | 18 | $14,760 | $820 |
| Cyclosporine | 20 | $14,268 | $713 |
| Simbrinza | 35 | $10,723 | $306 |
| Rhopressa | 18 | $8,979 | $499 |
| Latanoprost | 439 | $6,864 | $16 |
| Vyzulta | 15 | $6,657 | $444 |
| Travoprost | 15 | $3,148 | $210 |
| Loteprednol Etabonate | 21 | $2,723 | $130 |
| Tobramycin-Dexamethasone | 44 | $1,907 | $43 |
| Brimonidine Tartrate-Timolol | 12 | $1,531 | $128 |
| Timolol Maleate | 18 | $1,196 | $66 |
| Neomycin-Polymyxin-Dexameth | 106 | $998 | $9 |
| Dorzolamide-Timolol | 41 | $741 | $18 |
| Brimonidine | 45 | $683 | $15 |
| Moxifloxacin | 12 | $219 | $18 |
| Dorzolamide | 15 | $205 | $14 |
| Cephalexin | 26 | $143 | $5 |
Year by year
| 2024 | 1,097 | 377 | 0% (0) | 62% | $203,552 |
| 2023 | 1,107 | 387 | 0% (0) | 61% | $180,212 |
| 2022 | 979 | 316 | 0% (0) | 59% | $182,032 |
| 2021 | 998 | 296 | 0% (0) | 61% | $181,003 |
| 2020 | 848 | 276 | None | 57% | $197,545 |
| 2019 | 983 | 323 | None | 56% | $182,565 |
| 2018 | 1,234 | 349 | 0% (0) | 57% | $174,504 |
| 2017 | 1,368 | 371 | None | 57% | $196,778 |
| 2016 | 1,473 | 424 | 0% (0) | 58% | $178,695 |
| 2015 | 1,471 | 380 | None | 63% | $167,908 |
| 2014 | 1,590 | 398 | None | 62% | $155,315 |
| 2013 | 1,479 | 346 | None | 57% | $123,845 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Restasis | 33 | $41,171 | $1,248 |
| Lumigan | 41 | $23,616 | $576 |
| Xiidra | 12 | $14,487 | $1,207 |
| Rhopressa | 26 | $13,975 | $537 |
| Simbrinza | 28 | $10,580 | $378 |
| Latanoprost | 413 | $10,122 | $25 |
| Travoprost | 22 | $6,391 | $291 |
| Rocklatan | 12 | $4,235 | $353 |
| Alphagan P | 14 | $3,950 | $282 |
| Neomycin-Polymyxin-Dexameth | 158 | $2,178 | $14 |
| Tobramycin-Dexamethasone | 34 | $2,036 | $60 |
| Dorzolamide-Timolol | 61 | $1,677 | $27 |
| Timolol Maleate | 40 | $1,478 | $37 |
| Brimonidine | 40 | $1,015 | $25 |
| Dorzolamide | 28 | $585 | $21 |
| Moxifloxacin | 12 | $397 | $33 |
| Cephalexin | 21 | $265 | $13 |
2022: 17 drugs
| Restasis | 40 | $47,275 | $1,182 |
| Lumigan | 62 | $35,116 | $566 |
| Xiidra | 21 | $20,824 | $992 |
| Rhopressa | 18 | $11,620 | $646 |
| Latanoprost | 387 | $10,717 | $28 |
| Simbrinza | 24 | $7,710 | $321 |
| Alphagan P | 22 | $6,634 | $302 |
| Travoprost | 20 | $6,451 | $323 |
| Brimonidine | 34 | $3,074 | $90 |
| Dorzolamide-Timolol | 71 | $2,013 | $28 |
| Neomycin-Polymyxin-Dexameth | 109 | $1,505 | $14 |
| Tobramycin-Dexamethasone | 17 | $1,439 | $85 |
| Timolol Maleate | 18 | $1,085 | $60 |
| Prednisolone Acetate | 12 | $664 | $55 |
| Levobunolol | 11 | $470 | $43 |
| Dorzolamide | 23 | $432 | $19 |
| Cephalexin | 16 | $83 | $5 |
2021: 17 drugs
| Restasis | 46 | $50,773 | $1,104 |
| Lumigan | 64 | $34,255 | $535 |
| Xiidra | 29 | $21,444 | $739 |
| Latanoprost | 355 | $11,232 | $32 |
| Rhopressa | 29 | $10,698 | $369 |
| Alphagan P | 18 | $7,349 | $408 |
| Combigan | 18 | $7,030 | $391 |
| Vyzulta | 11 | $6,687 | $608 |
| Travoprost | 18 | $5,222 | $290 |
| Brimonidine | 36 | $3,211 | $89 |
| Tobradex | 11 | $2,665 | $242 |
| Timolol Maleate | 34 | $2,274 | $67 |
| Dorzolamide-Timolol | 85 | $2,075 | $24 |
| Neomycin-Polymyxin-Dexameth | 104 | $1,409 | $14 |
| Tobramycin-Dexamethasone | 13 | $966 | $74 |
| Dorzolamide | 27 | $887 | $33 |
| Cephalexin | 21 | $147 | $7 |
2020: 17 drugs
| Restasis | 66 | $76,649 | $1,161 |
| Lumigan | 82 | $35,777 | $436 |
| Rhopressa | 31 | $16,941 | $546 |
| Xiidra | 16 | $10,857 | $679 |
| Combigan | 18 | $9,102 | $506 |
| Latanoprost | 294 | $8,636 | $29 |
| Alphagan P | 18 | $7,428 | $413 |
| Azopt | 12 | $5,271 | $439 |
| Brimonidine | 33 | $3,883 | $118 |
| Travoprost | 12 | $3,831 | $319 |
| Simbrinza | 11 | $3,411 | $310 |
| Dorzolamide-Timolol | 41 | $2,556 | $62 |
| Tobramycin-Dexamethasone | 24 | $1,842 | $77 |
| Olopatadine | 24 | $1,304 | $54 |
| Neomycin-Polymyxin-Dexameth | 55 | $953 | $17 |
| Dorzolamide | 13 | $692 | $53 |
| Cephalexin | 15 | $78 | $5 |
2019: 22 drugs
| Restasis | 50 | $55,794 | $1,116 |
| Lumigan | 79 | $32,088 | $406 |
| Xiidra | 14 | $8,938 | $638 |
| Alphagan P | 20 | $8,464 | $423 |
| Azopt | 19 | $8,081 | $425 |
| Latanoprost | 273 | $7,697 | $28 |
| Simbrinza | 20 | $6,594 | $330 |
| Travatan Z | 19 | $6,362 | $335 |
| Ilevro | 14 | $4,809 | $343 |
| Pazeo | 21 | $4,691 | $223 |
| Dorzolamide-Timolol | 42 | $3,376 | $80 |
| Durezol | 15 | $3,115 | $208 |
| Tobramycin-Dexamethasone | 30 | $2,692 | $90 |
| Brimonidine | 20 | $2,190 | $110 |
| Olopatadine | 25 | $1,688 | $68 |
| Moxifloxacin | 39 | $1,325 | $34 |
| Neomycin-Polymyxin-Dexameth | 78 | $1,248 | $16 |
| Prednisolone Acetate | 33 | $1,147 | $35 |
| Dorzolamide | 11 | $707 | $64 |
| Timolol Maleate | 19 | $425 | $22 |
| Ofloxacin | 26 | $409 | $16 |
| Levobunolol | 13 | $170 | $13 |
2018: 23 drugs
| Lumigan | 78 | $25,888 | $332 |
| Restasis | 23 | $23,307 | $1,013 |
| Restasis Multidose | 24 | $18,248 | $760 |
| Prolensa | 55 | $14,059 | $256 |
| Travatan Z | 34 | $10,064 | $296 |
| Xiidra | 16 | $9,664 | $604 |
| Latanoprost | 266 | $7,475 | $28 |
| Azopt | 13 | $6,938 | $534 |
| Combigan | 17 | $6,394 | $376 |
| Alphagan P | 18 | $6,272 | $348 |
| Simbrinza | 26 | $5,834 | $224 |
| Ilevro | 20 | $5,145 | $257 |
| Pazeo | 23 | $5,090 | $221 |
| Prednisolone Acetate | 137 | $5,076 | $37 |
| Brimonidine | 35 | $3,764 | $108 |
| Tobramycin-Dexamethasone | 39 | $2,830 | $73 |
| Durezol | 15 | $2,656 | $177 |
| Moxifloxacin | 52 | $2,405 | $46 |
| Olopatadine | 29 | $1,735 | $60 |
| Ofloxacin | 107 | $1,570 | $15 |
| Dorzolamide-Timolol | 39 | $1,496 | $38 |
| Neomycin-Polymyxin-Dexameth | 72 | $1,121 | $16 |
| Timolol Maleate | 25 | $788 | $32 |
2017: 25 drugs
| Restasis | 43 | $36,445 | $848 |
| Lumigan | 105 | $34,433 | $328 |
| Ilevro | 49 | $12,862 | $262 |
| Travatan Z | 41 | $11,884 | $290 |
| Prolensa | 42 | $9,728 | $232 |
| Azopt | 17 | $8,184 | $481 |
| Vigamox | 48 | $7,505 | $156 |
| Alphagan P | 27 | $7,477 | $277 |
| Durezol | 45 | $7,382 | $164 |
| Latanoprost | 300 | $7,032 | $23 |
| Combigan | 22 | $5,942 | $270 |
| Simbrinza | 22 | $5,430 | $247 |
| Prednisolone Acetate | 105 | $4,989 | $48 |
| Xiidra | 11 | $4,985 | $453 |
| Brimonidine | 33 | $4,080 | $124 |
| Tobramycin-Dexamethasone | 30 | $2,444 | $81 |
| Pazeo | 14 | $2,314 | $165 |
| Olopatadine | 20 | $1,902 | $95 |
| Dorzolamide-Timolol | 53 | $1,399 | $26 |
| Ofloxacin | 87 | $1,345 | $15 |
| Timolol Maleate | 28 | $1,339 | $48 |
| Neomycin-Polymyxin-Dexameth | 88 | $1,296 | $15 |
| Dorzolamide | 13 | $232 | $18 |
| Tobramycin | 15 | $144 | $10 |
| Cephalexin | 11 | $93 | $8 |
2016: 24 drugs
| Restasis | 40 | $32,553 | $814 |
| Lumigan | 88 | $25,562 | $290 |
| Ilevro | 85 | $20,377 | $240 |
| Vigamox | 113 | $17,185 | $152 |
| Travatan Z | 53 | $16,131 | $304 |
| Durezol | 55 | $8,487 | $154 |
| Latanoprost | 361 | $6,736 | $19 |
| Alphagan P | 35 | $6,586 | $188 |
| Azopt | 14 | $6,361 | $454 |
| Combigan | 25 | $5,263 | $211 |
| Prednisolone Acetate | 105 | $4,594 | $44 |
| Brimonidine | 26 | $3,554 | $137 |
| Tobramycin-Dexamethasone | 44 | $3,330 | $76 |
| Prolensa | 15 | $3,076 | $205 |
| Pataday | 19 | $3,012 | $159 |
| Simbrinza | 20 | $2,927 | $146 |
| Dorzolamide-Timolol | 78 | $1,889 | $24 |
| Neomycin-Polymyxin-Dexameth | 98 | $1,656 | $17 |
| Timolol Maleate | 31 | $762 | $25 |
| Ofloxacin | 26 | $413 | $16 |
| Dorzolamide | 14 | $232 | $17 |
| Diclofenac | 15 | $165 | $11 |
| Cephalexin | 17 | $152 | $9 |
| Ciprofloxacin | 12 | $106 | $9 |
2015: 25 drugs
| Lumigan | 123 | $31,740 | $258 |
| Restasis | 44 | $24,662 | $561 |
| Travatan Z | 83 | $16,692 | $201 |
| Vigamox | 112 | $15,011 | $134 |
| Ilevro | 64 | $14,098 | $220 |
| Pataday | 31 | $6,220 | $201 |
| Durezol | 41 | $6,047 | $147 |
| Azopt | 24 | $5,955 | $248 |
| Alphagan P | 31 | $5,088 | $164 |
| Latanoprost | 354 | $5,075 | $14 |
| Patanol | 17 | $4,530 | $266 |
| Prednisolone Acetate | 90 | $4,110 | $46 |
| Tobramycin-Dexamethasone | 37 | $2,940 | $79 |
| Simbrinza | 18 | $2,782 | $155 |
| Prolensa | 13 | $2,777 | $214 |
| Lotemax | 12 | $2,197 | $183 |
| Combigan | 13 | $2,008 | $154 |
| Brimonidine | 17 | $1,914 | $113 |
| Moxeza | 14 | $1,807 | $129 |
| Neomycin-Polymyxin-Dexameth | 93 | $1,448 | $16 |
| Dorzolamide-Timolol | 43 | $1,054 | $25 |
| Timolol Maleate | 58 | $975 | $17 |
| Azelastine | 11 | $512 | $47 |
| Dorzolamide | 14 | $386 | $28 |
| Cephalexin | 23 | $122 | $5 |
2014: 26 drugs
| Restasis | 51 | $26,242 | $515 |
| Lumigan | 116 | $24,329 | $210 |
| Vigamox | 136 | $15,277 | $112 |
| Ilevro | 77 | $13,278 | $172 |
| Travatan Z | 69 | $12,390 | $180 |
| Prednisolone Acetate | 147 | $6,806 | $46 |
| Latanoprost | 376 | $6,099 | $16 |
| Azopt | 34 | $5,947 | $175 |
| Prolensa | 29 | $5,603 | $193 |
| Pataday | 29 | $4,145 | $143 |
| Tobramycin-Dexamethasone | 46 | $3,847 | $84 |
| Alphagan P | 23 | $3,547 | $154 |
| Lotemax | 24 | $3,469 | $145 |
| Patanol | 12 | $2,862 | $238 |
| Nevanac | 16 | $2,675 | $167 |
| Durezol | 18 | $2,331 | $129 |
| Combigan | 18 | $2,119 | $118 |
| Brimonidine | 23 | $1,863 | $81 |
| Neomycin-Polymyxin-Dexameth | 84 | $1,437 | $17 |
| Dorzolamide | 20 | $1,153 | $58 |
| Dorzolamide-Timolol | 39 | $1,018 | $26 |
| Levobunolol | 21 | $957 | $46 |
| Timolol Maleate | 47 | $814 | $17 |
| Diclofenac | 24 | $315 | $13 |
| Tobramycin | 12 | $130 | $11 |
| Ofloxacin | 11 | $94 | $9 |
2013: 23 drugs
| Lumigan | 119 | $21,162 | $178 |
| Travatan Z | 83 | $14,234 | $171 |
| Restasis | 35 | $13,043 | $373 |
| Nevanac | 85 | $12,652 | $149 |
| Vigamox | 123 | $12,448 | $101 |
| Latanoprost | 376 | $7,682 | $20 |
| Durezol | 54 | $5,968 | $111 |
| Azopt | 30 | $4,902 | $163 |
| Pataday | 28 | $3,508 | $125 |
| Tobramycin-Dexamethasone | 32 | $2,890 | $90 |
| Combigan | 22 | $2,741 | $125 |
| Alphagan P | 19 | $2,527 | $133 |
| Dorzolamide-Timolol | 68 | $2,458 | $36 |
| Brimonidine | 25 | $2,270 | $91 |
| Ilevro | 13 | $1,935 | $149 |
| Timolol Maleate | 67 | $1,770 | $26 |
| Lotemax | 13 | $1,657 | $127 |
| Neomycin-Polymyxin-Dexameth | 84 | $1,422 | $17 |
| Prednisolone Acetate | 71 | $1,212 | $17 |
| Levobunolol | 16 | $725 | $45 |
| Dorzolamide | 15 | $668 | $45 |
| Acetazolamide | 17 | $222 | $13 |
| Tobramycin | 17 | $194 | $11 |
Money from drug and device companies
$878 in 2025
| 2025 | 10 | 29 | None | $878 |
| 2024 | 8 | 18 | None | $405 |
| 2023 | 8 | 25 | None | $535 |
| 2022 | 6 | 14 | $238 | $541 |
| 2021 | 6 | 14 | None | $260 |
| 2020 | 6 | 18 | None | $297 |
| 2019 | 8 | 20 | None | $576 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Durysta | $235 | 6 payments
|
| Alcon Vision | Tryptyr | $182 | 9 payments
|
| RxSight | Rxsight Contact Lens | $148 | 1 payment
|
| Amgen | Tepezza | $80 | 3 payments
|
| Sun Pharmaceutical Industries | Cequa | $52 | 2 payments
|
| Bausch & Lomb Americas | Miebo | $50 | 2 payments
|
See all 29 published payments
| Oyster Point Pharma | Meals · 2025-12-15 | Tyrvaya | $27 |
| Alcon Vision | Meals · 2025-11-17 | Tryptyr | $9 |
| Alcon Vision | Meals · 2025-10-27 | Tryptyr | $25 |
| Abbvie | Meals · 2025-10-20 | Lumigan | $26 |
| Abbvie | Meals · 2025-10-10 | Lumigan | $9 |
| Abbvie | Meals · 2025-10-09 | Durysta | $124 |
| Amgen | Meals · 2025-09-29 | Tepezza | $27 |
| Oyster Point Pharma | Meals · 2025-09-13 | Tyrvaya | $19 |
| Alcon Vision | Meals · 2025-09-08 | Tryptyr | $21 |
| Sun Pharmaceutical Industries | Meals · 2025-09-08 | Cequa | $26 |
| Thea Pharma | Meals · 2025-08-30 | Iyuzeh | $22 |
| Amgen | Meals · 2025-08-15 | Tepezza | $26 |
| Mallinckrodt Hospital Products | Meals · 2025-08-04 | Acthar | $24 |
| Alcon Vision | Meals · 2025-07-28 | Tryptyr | $31 |
| Abbvie | Meals · 2025-07-10 | Lumigan | $8 |
| Bausch & Lomb Americas | Meals · 2025-07-08 | Miebo | $25 |
| Alcon Vision | Meals · 2025-07-02 | Eysuvis | $12 |
| Bausch & Lomb Americas | Meals · 2025-07-01 | Vyzulta | $25 |
| Alcon Vision | Meals · 2025-06-23 | Eysuvis | $25 |
| Alcon Vision | Meals · 2025-06-12 | Eysuvis | $18 |
| Thea Pharma | Meals · 2025-06-11 | Iyuzeh | $20 |
| Alcon Vision | Meals · 2025-05-06 | Eysuvis | $20 |
| Alcon Vision | Meals · 2025-05-05 | Rocklatan | $21 |
| Sun Pharmaceutical Industries | Meals · 2025-04-21 | Cequa | $26 |
| Tarsus Pharmaceuticals | Meals · 2025-04-07 | Xdemvy | $20 |
| Abbvie | Meals · 2025-03-28 | Lumigan | $35 |
| Amgen | Meals · 2025-03-24 | Tepezza | $26 |
| RxSight | Meals · 2025-03-13 | Rxsight Contact Lens | $148 |
| Abbvie | Meals · 2025-01-11 | Lumigan | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $405
| Sun Pharmaceutical Industries | Cequa | $109 | 5 payments
|
| Bausch & Lomb Americas | Miebo | $82 | 4 payments
|
| Alcon Vision | Rocklatan | $63 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $40 | 2 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $40 | 2 payments
|
| Abbvie | Lumigan | $25 | 1 payment
|
| Thea Pharma | Iyuzeh | $23 | 1 payment
|
| Optos | Nfc-700 | $22 | 1 payment
|
2023: $535
| Oyster Point Pharma | Tyrvaya | $160 | 8 payments
|
| Novartis Pharmaceuticals | Xiidra | $132 | 6 payments
|
| Sun Pharmaceutical Industries | Cequa | $95 | 4 payments
|
| Abbvie | Lumigan | $46 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $45 | 2 payments
|
| Bausch & Lomb Americas | Miebo | $25 | 1 payment
|
| Astellas Pharma US | Izervay | $19 | 1 payment
|
| Alcon Vision | Rocklatan | $14 | 1 payment
|
2022: $541
| Notal Vision | None | $238 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $79 | 3 payments
|
| Sun Pharmaceutical Industries | Cequa | $72 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $65 | 3 payments
|
| Kala Pharmaceuticals | Inveltys | $45 | 2 payments
|
| Alcon Vision | Rhopressa | $42 | 2 payments
|
2021: $260
| Aerie Pharmaceuticals | Rhopressa | $82 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $54 | 3 payments
|
| Kala Pharmaceuticals | Inveltys | $41 | 2 payments
|
| Eyevance Pharmaceuticals | Tobradex St | $36 | 2 payments
|
| Allergan | Restasis Multidose | $32 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $15 | 1 payment
|
2020: $297
| Sun Pharmaceutical Industries | Cequa | $113 | 8 payments
|
| Allergan | Restasis | $71 | 4 payments
|
| Aerie Pharmaceuticals | Rocklatan | $38 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $31 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $23 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $22 | 1 payment
|
2019: $576
| Aerie Pharmaceuticals | Rhopressa | $265 | 5 payments
|
| Allergan | Lumigan | $71 | 4 payments
|
| Sun Pharmaceutical Industries | Bromsite | $62 | 3 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $56 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $47 | 2 payments
|
| TissueTech | Prokera | $34 | 1 payment
|
| Akorn | Zioptan | $23 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386683191
- Licence
- CA A37122California A37122: Current · expires 2027-03-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A371220
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 10300 S De Anza Blvd, Cupertino, CA, 95014
- NPI first listed
- 2006-06-06
- NPI last updated
- 2011-11-23
This is when the NPI record was last certified, not a medical board exam.